Activation of EVI1 Gene Expression in Human Acute Myelogenous Leukemias by Translocations Spanning 300-400 Kilobases on Chromosome Band 3q26

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1992 May 1

PMID 1570317

Citations 63

Authors

K Morishita

E Parganas

C L William

M H Whittaker

H Drabkin

J Oval

R Taetle

M B Valentine

J N Ihle

Affiliations

Soon will be listed here.

Abstract

Retroviral activation of Evi-1 gene expression is one of the most common transforming events in murine myeloid leukemias. To evaluate the role of the EVI1 gene in human acute myelogenous leukemia (AML), leukemic blasts or cell lines from 116 patients were examined. In eight patients the EVI1 gene was expressed and all but one had cytogenetically detectable translocations of chromosome 3q26 where the EVI1 gene has been localized. To identify breakpoints, a restriction map that spans 1700 kilobases (kb) of the EVI1 locus was developed by pulsed-field gel electrophoresis. In one case, t(3;3)(q21;q26), a rearrangement was localized to 170-330 kb 5' of the gene. In a second case, t(3;3)(q21;q26), there was a rearrangement 13 kb 5' of the gene. This rearrangement was cloned and shown to be due to the fusion of sequences from 3q21-22 with the EVI1 locus. In the third case, ins(3)-(q21q25q27), there was a rearrangement that mapped 150 kb downstream from the 5' end of the gene.

Citing Articles

Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Marchesini M, Gherli A, Simoncini E, Moron Dalla Tor L, Montanaro A, Thongon N Nat Commun. 2024; 15(1):4739.

PMID: 38834613 PMC: 11150407. DOI: 10.1038/s41467-024-48953-3.

Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors.

Ikeda D, Chi S, Uchiyama S, Nakamura H, Guo Y, Yamauchi N Int J Mol Sci. 2022; 23(11).

PMID: 35682627 PMC: 9180585. DOI: 10.3390/ijms23115950.

Acute megakaryoblastic leukemia with trisomy 3 and CBFA2T3::GLIS2: A case report.

Gillam J, Catic A, Paulraj P, Dalton J, Lai G, Jackson-Cook C Genes Chromosomes Cancer. 2022; 61(8):491-496.

PMID: 35294081 PMC: 9544894. DOI: 10.1002/gcc.23039.

Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia.

Smeenk L, Ottema S, Mulet-Lazaro R, Ebert A, Havermans M, Arricibita Varea A Cancer Discov. 2021; 11(11):2868-2883.

PMID: 33980539 PMC: 8563373. DOI: 10.1158/2159-8290.CD-20-1793.

Concurrent Central Diabetes Insipidus and Acute Myeloid Leukemia.

Pritzl S, Matson D, Juckett M, Ciske D Case Rep Hematol. 2021; 2021:8898671.

PMID: 33643671 PMC: 7902136. DOI: 10.1155/2021/8898671.

References

Bitter M, Neilly M, Le Beau M, Pearson M, Rowley J . Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia. Blood. 1985; 66(6):1362-70. View

Bernstein R, Bagg A, Pinto M, Lewis D, Mendelow B . Chromosome 3q21 abnormalities associated with hyperactive thrombopoiesis in acute blastic transformation of chronic myeloid leukemia. Blood. 1986; 68(3):652-7. View

Matsugi T, Morishita K, Ihle J . Identification, nuclear localization, and DNA-binding activity of the zinc finger protein encoded by the Evi-1 myeloid transforming gene. Mol Cell Biol. 1990; 10(3):1259-64. PMC: 361017. DOI: 10.1128/mcb.10.3.1259-1264.1990. View

Walter T, Morgan R, Ondreyco S, Sandberg A . Apparent duplication of inv(3)(q21q26) in one of five cases with inv (3) in myelodysplastic syndromes and acute leukemia. Am J Hematol. 1990; 33(3):210-4. DOI: 10.1002/ajh.2830330310. View

Rowley J . Identification of the constant chromosome regions involved in human hematologic malignant disease. Science. 1982; 216(4547):749-51. DOI: 10.1126/science.7079737. View

Rowley J, Potter D . Chromosomal banding patterns in acute nonlymphocytic leukemia. Blood. 1976; 47(5):705-21. View

Motokura T, Bloom T, Kim H, Juppner H, Ruderman J, Kronenberg H . A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991; 350(6318):512-5. DOI: 10.1038/350512a0. View

Morishita K, Parganas E, Matsugi T, Ihle J . Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol Cell Biol. 1992; 12(1):183-9. PMC: 364082. DOI: 10.1128/mcb.12.1.183-189.1992. View

Morishita K, Parganas E, Parham D, Matsugi T, Ihle J . The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes. Oncogene. 1990; 5(9):1419-23. View

10.

Oval J, Jones O, Montoya M, Taetle R . Characterization of a factor-dependent acute leukemia cell line with translocation (3;3)(q21;q26). Blood. 1990; 76(7):1369-74. View

11.

Bartholomew C, Ihle J . Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter. Mol Cell Biol. 1991; 11(4):1820-8. PMC: 359852. DOI: 10.1128/mcb.11.4.1820-1828.1991. View

12.

Perkins A, Fishel R, Jenkins N, Copeland N . Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein. Mol Cell Biol. 1991; 11(5):2665-74. PMC: 360036. DOI: 10.1128/mcb.11.5.2665-2674.1991. View

13.

Rubin C, Larson R, Anastasi J, Winter J, Thangavelu M, Vardiman J . t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood. 1990; 76(12):2594-8. View

14.

Brown L, Cheng J, Chen Q, Siciliano M, Crist W, Buchanan G . Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J. 1990; 9(10):3343-51. PMC: 552072. DOI: 10.1002/j.1460-2075.1990.tb07535.x. View

15.

Bird A . CpG-rich islands and the function of DNA methylation. Nature. 1986; 321(6067):209-13. DOI: 10.1038/321209a0. View

16.

Bartholomew C, Morishita K, Askew D, BUCHBERG A, Jenkins N, Copeland N . Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene. Oncogene. 1989; 4(5):529-34. View

17.

Henglein B, Synovzik H, Groitl P, Bornkamm G, Hartl P, Lipp M . Three breakpoints of variant t(2;8) translocations in Burkitt's lymphoma cells fall within a region 140 kilobases distal from c-myc. Mol Cell Biol. 1989; 9(5):2105-13. PMC: 363004. DOI: 10.1128/mcb.9.5.2105-2113.1989. View

18.

Morishita K, Parker D, Mucenski M, Jenkins N, Copeland N, Ihle J . Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell. 1988; 54(6):831-40. DOI: 10.1016/s0092-8674(88)91175-0. View

19.

Mucenski M, Taylor B, Ihle J, Hartley J, Morse 3rd H, Jenkins N . Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol. 1988; 8(1):301-8. PMC: 363121. DOI: 10.1128/mcb.8.1.301-308.1988. View

20.

Bordereaux D, Fichelson S, Sola B, Tambourin P, Gisselbrecht S . Frequent involvement of the fim-3 region in Friend murine leukemia virus-induced mouse myeloblastic leukemias. J Virol. 1987; 61(12):4043-5. PMC: 256030. DOI: 10.1128/JVI.61.12.4043-4045.1987. View